Biologics Safety Testing Market Expected To Value US$ 4.36 Bn By 2022

Quality control measures for drug development are of utmost importance as
inadvertent presence of unknown pharmaceutical ingredients can further complicate
health conditions of the patients. Government authorities are closely watching over
pharmaceutical companies and regulating their drug manufacturing processes by
compelling them to undertake safety tests. Large and complex molecules such as
biologics, which are produced from genes of living organisms through advanced
DNA technologies, are also being tested for their safety in biopharmaceutical
Biotechnological companies and pharmaceutical manufacturers continue to give high
regards for biologics safety testing products and services. The efficacy of biologics
safety testing ensures that tested medicine and drugs are not containing any extra
ingredient, thereby preventing patients from experiencing adverse reactions upon
intake. A recently published report by Persistence Market Research projects that the
global market for biologics safety testing will soar at a robust CAGR of 8.8% over
the forecast period, 2017-2022. The report anticipates that approx. US$ 4.36 Bn
worth of biologics safety testing products & services will be utilized globally by the
end of 2022.
Request to view table of content @
According to the report, North America will remain at the forefront of global
expansion of biologics safety testing market. Throughout the forecast period, North
America is anticipated to remain the largest market for biologics safety testing
products & services. Key drug regulatory bodies such as the FDA are based in North
America. Moreover, the overall healthcare infrastructure in the US and Canada is
robust, and exhibits a high uptake for new and improved safety tests on biologics.
The biologics safety testing market in Europe is also expected to witness impressive
growth. Global leaders in biopharmaceutical production are expanding their presence
in European countries such as Germany and the UK. Moreover, the European region
continues to showcase a scientifically- and technologically-advanced healthcare
marketplace for biologics safety testing.
Request Sample Report @
Likewise, Japan’s biologics safety testing market is also anticipated to incur rapid
growth at a CAGR of 9.3%. Meanwhile the Asia-Pacific excluding Japan (APEJ)
region is anticipated to witness stellar growth, particularly with respect to
manufacturing of biologics safety testing products. Low wages and favorable
industrial regulations are expected to bolster the manufacturing of biologics safety
testing products in the APEJ region. Between 2017 and 2022, the APEJ biologics
safety testing market is estimated to create over US$ 270 Mn in absolute dollar
In 2017, endotoxin tests will account for nearly one-third share on global revenues.
The demand for adventitious agent detection tests will incur a relatively sluggish
growth towards the latter half of the forecast period. While kits and reagents will
remain top-selling products, the global market for biologics safety testing will
register higher traction for services, revenues from which are slated to grow at a
CAGR of 9%. Vaccine and therapeutics development, the largest application for
biologics safety testing, will be bringing in revenues worth over US$ 1.68 Bn by the
end of 2022.
Wuxi Apptec, Lonza Group Ltd., Toxikon Corporation, BioMerieux SA, Pace
Analytical Services Inc., Thermo Fisher Scientific Inc., Genscript Biotech Corp.,
Eurofins Scientific Se, SGS S.A., Sigma-Aldrich Corporation (Merck KGaA), and
Charles River Laboratories International, Inc. are profiled as key players in the global
market for biologics safety testing. These companies are anticipated to remain active
in the expansion of global biologics safety testing market through 2022.
Buy Biologics Safety Testing Market Report @
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research
model is a unique collaboration of data analytics and market research methodology to
help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from multidimensional sources. By deploying real-time data collection, big data, and customer
experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA,Canada Toll Free: 800-961-0353
Email: [email protected]